SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-23-011439
Filing Date
2023-03-31
Accepted
2023-03-31 17:20:29
Documents
11
Period of Report
2023-05-31

Document Format Files

Seq Description Document Type Size
1 PRE 14A 2023_prelim_proxy.htm PRE 14A 2838410
2 GRAPHIC img242713596_0.jpg GRAPHIC 3209
3 GRAPHIC img242713596_1.jpg GRAPHIC 11708
4 GRAPHIC img242713596_2.jpg GRAPHIC 3209
5 GRAPHIC img242713596_3.jpg GRAPHIC 8847
6 GRAPHIC img242713596_4.jpg GRAPHIC 65885
7 GRAPHIC img242713596_5.jpg GRAPHIC 64165
8 GRAPHIC img242713596_6.jpg GRAPHIC 8847
9 GRAPHIC img242713596_7.jpg GRAPHIC 3209
10 GRAPHIC img242713596_8.jpg GRAPHIC 1003
11 GRAPHIC img242713596_9.jpg GRAPHIC 2302
  Complete submission text file 0000950170-23-011439.txt   3078382
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

IRS No.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-20859 | Film No.: 23789236
SIC: 2834 Pharmaceutical Preparations